Blasi Claudio
Centro Diabete, ASLRMB-1D, Largo T. Solera n.10, 00199, Rome, Italy.
Obes Surg. 2016 Dec;26(12):3045-3057. doi: 10.1007/s11695-016-2419-2.
The current treatment for obesity-related type 2 diabetes is not able to achieve sufficient metabolic control. New remission prospects have been offered through bariatric surgery and other interventional therapies. The aim of the study is to illustrate the mechanism by which such therapies affect the autonomic system, in particular the afferent vagal activity. The first and most important terminal of this activity is the brainstem vagal nucleus tractus solitarius. Its function, on which the vagal efferent inputs that control the splanchnic organs depend, is conditioned by the level of synaptic transmission within it. In conclusion, on the basis of such a view, a selective pharmacological modulation of such transmission as the target for future medical treatment of obesity and related type 2 diabetes is proposed.
目前针对肥胖相关2型糖尿病的治疗方法无法实现充分的代谢控制。减肥手术和其他介入疗法带来了新的缓解前景。本研究的目的是阐明这些疗法影响自主神经系统,特别是传入迷走神经活动的机制。这种活动的第一个也是最重要的终末是脑干迷走神经孤束核。其功能是控制内脏器官的迷走神经传出输入所依赖的,它受到其内部突触传递水平的制约。总之,基于这样的观点,提出对这种传递进行选择性药理调节,作为未来肥胖及相关2型糖尿病医学治疗的靶点。